Shares of Owens & Minor (NYSE: OMI) surged 9.41% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results. The healthcare solutions company reported earnings that surpassed analyst expectations and provided an optimistic outlook for the full year.
Owens & Minor announced an adjusted earnings per share (EPS) of $0.23 for Q1, beating the consensus estimate of $0.20 by 15%. This represents a 21.05% increase from the same period last year. The company's adjusted net income reached $18.1 million, significantly exceeding the estimated $15.5 million. Additionally, adjusted EBITDA came in at $121.9 million, surpassing the projected $114.4 million.
While Q1 revenue slightly missed expectations at $2,632 million compared to the estimated $2,658 million, investors seemed to focus on the company's strong bottom-line performance and positive outlook. Owens & Minor provided full-year 2025 guidance, projecting revenue between $10,850 million and $11,150 million, adjusted EPS of $1.60 to $1.85, and adjusted EBITDA ranging from $560 million to $590 million. The company also revealed that it remains actively engaged in the potential sale of its Products & Healthcare Services segment, which could further streamline operations and unlock shareholder value.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.